# Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4

Study · id `cardio:ct-nct01632371` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01632371](<https://clinicaltrials.gov/study/NCT01632371>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01632371

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.

## Technical summary

Registry record NCT01632371. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 252 participants (enrolled count; ClinicalTrials.gov record NCT01632371, source copy `cardio:ctgov-nct01632371-2016-11-21`, retrieved 2026-10-31)
- Start date: 2012-06 (registry gives no type) (ClinicalTrials.gov record NCT01632371, source copy `cardio:ctgov-nct01632371-2016-11-21`, retrieved 2026-10-31)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT01632371, source copy `cardio:ctgov-nct01632371-2016-11-21`, retrieved 2026-10-31)
- Completion: 2016-11 (actual) (ClinicalTrials.gov record NCT01632371, source copy `cardio:ctgov-nct01632371-2016-11-21`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT01632371, source copy `cardio:ctgov-nct01632371-2016-11-21`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01632371-2016-11-21`, retrieved 2026-10-31)

## The registry's words

- Brief title: Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4
- Acronym: ISAR-DESIRE 4
- Condition: Restenosis
- Condition: Stable Angina Pectoris
- Condition: Acute Coronary Syndrome
- Intervention (Device): Paclitaxel Eluting Balloon + Scoring Balloon
- Intervention (Device): Paclitaxel Eluting Balloon
- Lead sponsor: Deutsches Herzzentrum Muenchen
- Lead sponsor class: OTHER
- Collaborator: Biotronik AG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Deutsches Herzzentrum Muenchen (`cardio:org-deutsches-herzzentrum-muenchen`)
- Registry lists this organization as a collaborator: Biotronik AG (`cardio:org-biotronik-ag`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial (`cardio:pubmed-28683939`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 17fb233302350f2876a0d2e9d2af1727558c5a1aaf683aa5d5d69a31f64821e3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
